| Juan Javier Servat, MD | |
|
3890 Johns Creek Pkwy Ste 240, Suwanee, GA 30024-1286 | |
| (770) 604-4141 | |
| (770) 604-4140 |
| Full Name | Juan Javier Servat |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 23 Years |
| Location | 3890 Johns Creek Pkwy Ste 240, Suwanee, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255530762 | NPI | - | NPPES |
| 003141770A | Medicaid | GA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellstar Douglas Hospital | Douglasville, GA | Hospital |
| St Mary's Hospital | Athens, GA | Hospital |
| Wellstar Kennestone Hospital | Marietta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oculofacial Plastic Surgeons Of Georgia, Llc | 8325181217 | 3 |
News Archive
Biothera today reported positive results from its proof of concept Phase 2 clinical trial in 90 patients with advanced non-small cell lung cancer (NSCLC) at the American Association for Cancer Research and the International Association for the Study of Lung Cancer joint conference on the Molecular Origins of Lung Cancer in San Diego.
DiaGenic has successfully finalized the first clinical study in collaboration with Pfizer, the market leader for Alzheimer's therapeutics sales and Pfizer has confirmed DiaGenic's findings resulting in a press release October 14th.
iMedX Inc., a leading healthcare software and services company, announced today that it has acquired the assets of PRN Medical Management, LLC, a medical transcription company serving medical clinics for over 18 years, primarily in Maryland, Washington DC, and Virginia. With the acquisition of PRN, iMedX expands its base in the Washington DC metro area and beyond. PRN's employees in India will be absorbed by iMedX's subsidiary Worldtech.
Analysis of the gut microbiome more successfully distinguished healthy individuals from those with precancerous adenomatous polyps and those with invasive colorectal cancer compared with assessment of clinical risk factors and fecal occult blood testing, according to data published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Toxcure, LLC, an emerging specialty biopharmaceutical company, today announced the grant of U.S. Patent No. 7,709,440, which provides Toxcure with intellectual property protection for a method of treating various tumors with neurotoxins.
› Verified 6 days ago
| Entity Name | Oculofacial Plastic Surgeons Of Georgia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871829192 PECOS PAC ID: 8325181217 Enrollment ID: O20100201000198 |
News Archive
Biothera today reported positive results from its proof of concept Phase 2 clinical trial in 90 patients with advanced non-small cell lung cancer (NSCLC) at the American Association for Cancer Research and the International Association for the Study of Lung Cancer joint conference on the Molecular Origins of Lung Cancer in San Diego.
DiaGenic has successfully finalized the first clinical study in collaboration with Pfizer, the market leader for Alzheimer's therapeutics sales and Pfizer has confirmed DiaGenic's findings resulting in a press release October 14th.
iMedX Inc., a leading healthcare software and services company, announced today that it has acquired the assets of PRN Medical Management, LLC, a medical transcription company serving medical clinics for over 18 years, primarily in Maryland, Washington DC, and Virginia. With the acquisition of PRN, iMedX expands its base in the Washington DC metro area and beyond. PRN's employees in India will be absorbed by iMedX's subsidiary Worldtech.
Analysis of the gut microbiome more successfully distinguished healthy individuals from those with precancerous adenomatous polyps and those with invasive colorectal cancer compared with assessment of clinical risk factors and fecal occult blood testing, according to data published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Toxcure, LLC, an emerging specialty biopharmaceutical company, today announced the grant of U.S. Patent No. 7,709,440, which provides Toxcure with intellectual property protection for a method of treating various tumors with neurotoxins.
› Verified 6 days ago
| Entity Name | Warner Robins Partners |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1235289448 PECOS PAC ID: 9638345861 Enrollment ID: O20120110000216 |
News Archive
Biothera today reported positive results from its proof of concept Phase 2 clinical trial in 90 patients with advanced non-small cell lung cancer (NSCLC) at the American Association for Cancer Research and the International Association for the Study of Lung Cancer joint conference on the Molecular Origins of Lung Cancer in San Diego.
DiaGenic has successfully finalized the first clinical study in collaboration with Pfizer, the market leader for Alzheimer's therapeutics sales and Pfizer has confirmed DiaGenic's findings resulting in a press release October 14th.
iMedX Inc., a leading healthcare software and services company, announced today that it has acquired the assets of PRN Medical Management, LLC, a medical transcription company serving medical clinics for over 18 years, primarily in Maryland, Washington DC, and Virginia. With the acquisition of PRN, iMedX expands its base in the Washington DC metro area and beyond. PRN's employees in India will be absorbed by iMedX's subsidiary Worldtech.
Analysis of the gut microbiome more successfully distinguished healthy individuals from those with precancerous adenomatous polyps and those with invasive colorectal cancer compared with assessment of clinical risk factors and fecal occult blood testing, according to data published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Toxcure, LLC, an emerging specialty biopharmaceutical company, today announced the grant of U.S. Patent No. 7,709,440, which provides Toxcure with intellectual property protection for a method of treating various tumors with neurotoxins.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juan Javier Servat, MD 3890 Johns Creek Pkwy Ste 245, Suwanee, GA 30024-6697 Ph: (770) 604-4141 | Juan Javier Servat, MD 3890 Johns Creek Pkwy Ste 240, Suwanee, GA 30024-1286 Ph: (770) 604-4141 |
News Archive
Biothera today reported positive results from its proof of concept Phase 2 clinical trial in 90 patients with advanced non-small cell lung cancer (NSCLC) at the American Association for Cancer Research and the International Association for the Study of Lung Cancer joint conference on the Molecular Origins of Lung Cancer in San Diego.
DiaGenic has successfully finalized the first clinical study in collaboration with Pfizer, the market leader for Alzheimer's therapeutics sales and Pfizer has confirmed DiaGenic's findings resulting in a press release October 14th.
iMedX Inc., a leading healthcare software and services company, announced today that it has acquired the assets of PRN Medical Management, LLC, a medical transcription company serving medical clinics for over 18 years, primarily in Maryland, Washington DC, and Virginia. With the acquisition of PRN, iMedX expands its base in the Washington DC metro area and beyond. PRN's employees in India will be absorbed by iMedX's subsidiary Worldtech.
Analysis of the gut microbiome more successfully distinguished healthy individuals from those with precancerous adenomatous polyps and those with invasive colorectal cancer compared with assessment of clinical risk factors and fecal occult blood testing, according to data published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Toxcure, LLC, an emerging specialty biopharmaceutical company, today announced the grant of U.S. Patent No. 7,709,440, which provides Toxcure with intellectual property protection for a method of treating various tumors with neurotoxins.
› Verified 6 days ago
Kiran Sajja, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1300 Peachtree Industrial Blvd, Suite 1201, Suwanee, GA 30024 Phone: 678-381-2020 Fax: 678-381-2015 | |
Jenna May Kim, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3890 Johns Creek Pkwy Ste 240, Suwanee, GA 30024 Phone: 770-604-4141 Fax: 770-604-4140 | |
Brice In Hwang, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1325 Satellite Blvd Nw Ste 208, Suwanee, GA 30024 Phone: 470-795-6460 Fax: 762-257-6942 | |
Jeffrey Tran, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5400 Laurel Springs Pkwy Ste 103, Suwanee, GA 30024 Phone: 470-403-2020 Fax: 470-805-2020 | |
Eric Bernat Baylin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3890 Johns Creek Pkwy Ste 240, Suwanee, GA 30024 Phone: 770-604-4141 Fax: 770-604-4140 |